Buscar
Mostrando ítems 1-10 de 2887
Antifungal therapy: New advances in the understanding and treatment of mycosis
(2017-01-23)
The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. Additionally, identifying novel drug targets is ...
Antifungal applications of Ag-decorated hydroxyapatite nanoparticles
(2013-08-19)
Pure hydroxyapatite (HA) and hydroxyapatite decorated with silver (HA@Ag) nanoparticles were synthesized and characterized. The antifungal effect of HA@Ag nanoparticles in a distilled water solution was evaluated against ...
Antifungal applications of Ag-decorated hydroxyapatite nanoparticles
(2013-08-19)
Pure hydroxyapatite (HA) and hydroxyapatite decorated with silver (HA@Ag) nanoparticles were synthesized and characterized. The antifungal effect of HA@Ag nanoparticles in a distilled water solution was evaluated against ...
Effect of cold atmospheric plasma jet associated to polyene antifungals on Candida albicans biofilms
(MDPI, 2021-09-25)
: The increasing incidence of antifungal resistance represents a great challenge in the medical area and, for this reason, new therapeutic alternatives for the treatment of fungal infections are urgently required. Cold ...
Effect of cold atmospheric plasma jet associated to polyene antifungals on candida albicans biofilms
(2021-10-01)
The increasing incidence of antifungal resistance represents a great challenge in the medical area and, for this reason, new therapeutic alternatives for the treatment of fungal infections are urgently required. Cold ...
Antifungal and post-antifungal effects of chlorhexidine, fluconazole, chitosan and its combinations on Candida albicans
(Medicina Oral, Patología Oral y Cirugía Bucal., 2011)
Objective: The aim of this work was to assess the antifungal and post-antifungal effects of chlorhexidine, fluconazole,
chitosan and its combinations on virulence factors of Candida albicans.
Study Design: Ten isolated ...
Alternative treatment of fungal infections: Synergy with non-antifungal agents
(Wiley Blackwell Publishing, Inc, 2021-03)
Fungal infections are responsible for high mortality rates in immunocompromised and high-risk surgical patients. Therapy failures during the last decades due to increasing multidrug resistance demand innovative strategies ...
In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species
(Wiley, 2013-04)
The strict nutritional requirements of Malassezia species make it difficult to test the antifungal susceptibility. Treatments of the chronic and recurrent infections associated with Malassezia spp. are usually ineffective. ...